/PRNewswire/ Capsida Biotherapeutics Inc. ("Capsida") today announced the appointment of Julie Hakim to the role of chief financial officer (CFO). Ms. Hakim.
BOOST Newbury Park-based Capsida Biotherapeutics just received a $55-million cash infusion from one of the nation’s biggest pharma firms. Acorn file photo The city’s fasting growing biotech startup has struck a deal with one of the biggest names in pharma. Capsida Biotherapeutics will receive a $55-million investment from Prevail, a subsidiary of Eli Lilly, the nation’s
Eli Lilly strikes $55 million deal with Capsida Biotherapeutics to develop gene therapies; Geron’s experimental drug for rare blood cancers shows efficacy.
BioSpace’s exclusive Hotbed Map highlights nine different regions to watch across the U.S. This map, made in vibrant color for BioSpace showcases a one-of-a-kind glance at some of 2023’s headline-making companies.
/PRNewswire/ Capsida Biotherapeutics Inc. ("Capsida") today announced a multi-year strategic collaboration with Prevail Therapeutics ("Prevail"), a wholly.